Immunization with a DNA vaccine cocktail induces a Th1 response and protects mice against Mycobacterium avium subsp.
Sung-Un Park1, Kumanan Kathaperumal, Sean McDonough
1College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Abstract:
Several antigens of Mycobacterium avium subsp. paratuberculosis have been studied as vaccine components and their immunogenicity has been evaluated. Previously, we reported that 85 antigen complex (85A, 85B, and 85C), superoxide dismutase (SOD), and 35kDa protein could induce significant lymphocyte proliferation as well as the elaboration of Th1-associated cytokines including interferon gamma (IFN-gamma), interleukin-2 (IL-2), IL-12 and tumor necrosis factor alpha (TNF-alpha). Based on these results, we cloned and expressed 85A, 85B, 85C, SOD, and 35kDa-protein genes into the eukaryotic expression plasmid pVR1020. C57BL/6 mice were immunized three times intramuscularly with the recombinant DNA cocktail and pVR1020 DNA alone as control. A significant reduction in the bacterial burden in the spleen and liver of mice immunized with the DNA cocktail as compared to the vector control group was found. Also, the relative severity of the liver and spleen histopathology paralleled the MAP culture results, more granulomas and acid-fast bacilli in the vector control animals. Moreover, mice immunized with the DNA cocktail developed both CD4(+) and CD8(+) T cell responses to the recombinant antigens and showed significant lymphocyte proliferation. The Th1 response related cytokine (IFN-gamma) levels increased in splenocytes obtained from immunized animals. These results indicate that the use of a recombinant DNA vaccine can provide protective immunity against mycobacterial infection by inducing a Th1 response.
Insights
This study developed a recombinant DNA vaccine using Mycobacterium antigens. Immunization reduced bacterial load and improved immune responses in mice, indicating potential protection against mycobacterial infections.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Mycobacterium avium subsp. paratuberculosis (MAP) infection poses a significant challenge.
- Previous research identified key MAP antigens (85A, 85B, 85C, SOD, 35kDa) that elicit Th1-associated immune responses.
Purpose of the Study:
- To develop and evaluate a recombinant DNA vaccine expressing selected MAP antigens.
- To assess the vaccine's efficacy in inducing protective immunity against MAP infection in a mouse model.
Main Methods:
- Cloning and expression of MAP antigen genes (85A, 85B, 85C, SOD, 35kDa) into a eukaryotic plasmid (pVR1020).
- Immunization of C57BL/6 mice with the recombinant DNA cocktail or control plasmid.
- Evaluation of bacterial burden, histopathology, T cell responses (CD4+, CD8+), lymphocyte proliferation, and Th1 cytokine (IFN-gamma) levels.
Main Results:
- DNA vaccine significantly reduced MAP bacterial burden in the spleen and liver.
- Histopathology showed reduced granulomas and acid-fast bacilli in vaccinated mice.
- Vaccination induced robust CD4+ and CD8+ T cell responses, lymphocyte proliferation, and increased IFN-gamma levels.
Conclusions:
- Recombinant DNA vaccine expressing MAP antigens elicits protective immunity.
- The vaccine induces a Th1-biased immune response, crucial for controlling mycobacterial infections.
- This approach shows promise for developing effective vaccines against MAP.
Related Concept Videos
Vaccines
Vaccinations


